肝星状细胞
细胞外基质
Wnt信号通路
细胞生物学
肝纤维化
生物
纤维化
SMAD公司
肝硬化
微泡
肝损伤
信号转导
免疫学
癌症研究
医学
病理
小RNA
内科学
内分泌学
基因
生物化学
作者
Yufei Yan,Jiefei Zeng,Linhao Xing,Changyong Li
出处
期刊:Biomedicines
[Multidisciplinary Digital Publishing Institute]
日期:2021-08-14
卷期号:9 (8): 1014-1014
被引量:105
标识
DOI:10.3390/biomedicines9081014
摘要
Hepatic fibrosis is characterized by the pathological accumulation of extracellular matrix (ECM) in the liver resulting from the persistent liver injury and wound-healing reaction induced by various insults. Although hepatic fibrosis is considered reversible after eliminating the cause of injury, chronic injury left unchecked can progress to cirrhosis and liver cancer. A better understanding of the cellular and molecular mechanisms controlling the fibrotic response is needed to develop novel clinical strategies. It is well documented that activated hepatic stellate cells (HSCs) is the most principal cellular players promoting synthesis and deposition of ECM components. In the current review, we discuss pathways of HSC activation, emphasizing emerging extra- and intra-cellular signals that drive this important cellular response to hepatic fibrosis. A number of cell types and external stimuli converge upon HSCs to promote their activation, including hepatocytes, liver sinusoidal endothelial cells, macrophages, cytokines, altered ECM, hepatitis viral infection, enteric dysbiosis, lipid metabolism disorder, exosomes, microRNAs, alcohol, drugs and parasites. We also discuss the emerging signaling pathways and intracellular events that individually or synergistically drive HSC activation, including TGFβ/Smad, Notch, Wnt/β-catenin, Hedgehog and Hippo signaling pathways. These findings will provide novel potential therapeutic targets to arrest or reverse fibrosis and cirrhosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI